QVT
ABBV icon

Quantitative Value Technologies’s AbbVie ABBV Stock Holding History

Quantitative Value Technologies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$360K Sell
3,196
-254
-7% -$28.6K 0.59% 66
2021
Q1 		$373K Buy
+3,450
New +$369K 0.8% 40

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Quantitative Value Technologies's ABBV Position: Q2 2021 in Review

Quantitative Value Technologies reduced its AbbVie (ABBV) stake by 7.4% in Q2 2021, selling an estimated $28.6K and leaving 3,196 shares worth $360K. The position accounts for 0.59% of the portfolio, ranked #66.

Quantitative Value Technologies first reported a position in ABBV in Q1 2021 and has held it in 2 quarters since. The position peaked at $373K in Q1 2021. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

  • Quantitative Value Technologies held 3,196 shares of AbbVie worth $360K as of Q2 2021.
  • Quantitative Value Technologies sold 254 AbbVie shares in Q2 2021, an estimated $28.6K.
  • AbbVie made up 0.59% of Quantitative Value Technologies's portfolio in Q2 2021, its #66 holding.
  • Quantitative Value Technologies first reported a position in AbbVie in Q1 2021 and has held it in 2 quarters since.
  • Quantitative Value Technologies's AbbVie position peaked at $373K in Q1 2021.
  • 2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Quantitative Value Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.